Superficial Femoral Artery Stenosis
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CordisS.M.A.R.T.™ Nitinol Stent System
Abbottfemoropopliteal revascularization for TASC C or TASC D lesion
Clinical Trials (2)
Total enrollment: 406 patients across 2 trials
Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease
Start: Jan 2026Est. completion: May 2026240 patients
N/ANot Yet Recruiting
Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions
Start: Jun 2020Est. completion: Jun 2026166 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 406 patients
2 companies competing in this space